CGON CG Oncology Market Value

Graphic logo of CG Oncology Corp (CGON)

The CG Oncology, Inc. (CGON) price chart, serving as confirmation of the market valuation, demonstrates the price action of an asset with a capitalization of 7.56. Business growth relies on an internal oncology drug development cycle, where the commercial success of bladder therapy outweighs macroeconomic factors. Risks are linked to potential trial failures and a dependence on external capital. While the application of AI automates screening, the clinical phase requires the direct involvement of medical professionals.

CGON cgoncology.com: Market Capitalization in the range 02/21/2024 - 11/17/2026

Metric breakdowns and analytics for cgoncology.com (CGON)

- current price and projected stock value:
Fundamental company valuation:CG Oncology Therapeutics CGON
Product sample of CG Oncology, Inc.

Market capitalization reflects the aggregate value of shares, which adjusts under the influence of interest rates and borrowing costs, allowing for an assessment of the business's actual scale relative to macroeconomic pressure. The market valuation dynamics of CG Oncology, Inc. (CGON) demonstrate the investment potential of developing bladder cancer immunotherapy for complex patients, confirming the fundamental resilience of this biotech asset within the urological oncology segment.

Competitors of CG Oncology, Inc. (CGON)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|UroGen (URGN) - Market Value|Market Capitalization BCAX|PSNL (Personalis Genomics) - Market Capitalization|Market Valuation Erasca Corp (ERAS)|Market Capitalization DCTH|Market Capitalization ymabs.com (YMAB)|Market Value Aura Bio AURA|CADL: Market Capitalization|Accuray, Inc. - Market Capitalization|Market Value SELLAS Life Sciences Group|ACTU: Market Capitalization|Market Value citiusonc.com (CTOR)|Market Value tuhurabio.com|TARA: Market Value|Market Valuation FATE (Fate Therapeutics Corp)|WHWK (Aadi Bioscience) - Market Value|Market Capitalization TCRX (TScan Therapeutics)|CSBR - Market Valuation|XBIT: Market Valuation|Market Value CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Market Value|Radiopharm Theranostics - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group